# LightSyn

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lightsyn

- Industry: Materials
- Headquarters: Hangzhou, China
- Website: www.lightsynbio.com
- Latest round: Series A (Jun 15, 2025)
- Investors on record: 4

## About

Established in 2023 and based in Hangzhou, China, LightSyn operates as an innovative molecular raw material developer that focuses on developing high value-added raw materials from microalgae using synthetic biology technology. The core members are from Tsinghua University, China Agricultural University, Chinese Academy of Sciences, University of Tokyo, and other universities.

In August 2023, LightSyn closed angel funding from new investor Morning Spring Venture. In June 2025, LightSyn closed a series A+ funding from new investors Jolmo Capital and Matwings Technology.

LightSyn mainly uses synthetic biology technology to develop high-value-added raw materials from microalgae. It has three technical platforms, which are microalgae germplasm resource library, experimental evolution transformation platform, and high-density fermentation amplification platform. Products include water-soluble small molecule ß-(1,3) glucan LS-01, EPA algae oil, mevalonate lactone Hyperpure-MVA, etc. The products can be used in beauty and personal care, food and health care, green agriculture, and other fields. The company generates revenue by providing microalgae high value-added raw materials such as water-soluble small molecule ß-(1,3) glucan LS-01, EPA algae oil, and mevalonate lactone Hyperpure-MVA.

## Funding rounds

- Series A, Jun 15, 2025 — Jolmo Capital, Matwings Technology
- Angel, Mar 28, 2024 — 3JS Investments, Jolmo Capital
- Angel, Aug 13, 2023 — Hangzhou Xiaochi Private Equity Fund Management

## Investors

- Hangzhou Xiaochi Private Equity Fund Management (https://capitalatlas.ai/funds/hangzhou-xiaochi-private-equity-fund-management) — Angel
- 3JS Investments — Angel
- Jolmo Capital (https://capitalatlas.ai/funds/jolmo-capital) — Angel, Series A
- Matwings Technology — Series A